(Q43169502)

English

Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer

scientific article published on 6 February 2010

In more languages
default for all languages
No label defined

No description defined

Statements

Pathologic response after neoadjuvant therapy is the major determinant of survival in patients with esophageal cancer (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit